CN109045141A - Chinese medicine composition, preparation and application - Google Patents
Chinese medicine composition, preparation and application Download PDFInfo
- Publication number
- CN109045141A CN109045141A CN201811278776.4A CN201811278776A CN109045141A CN 109045141 A CN109045141 A CN 109045141A CN 201811278776 A CN201811278776 A CN 201811278776A CN 109045141 A CN109045141 A CN 109045141A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- medicine composition
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims description 10
- 241001503991 Consolida Species 0.000 claims abstract description 8
- 235000004347 Perilla Nutrition 0.000 claims abstract description 6
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 6
- 241001526348 Myospalax Species 0.000 claims abstract description 4
- 241001251949 Xanthium sibiricum Species 0.000 claims abstract description 4
- 241001251068 Formica fusca Species 0.000 claims abstract description 3
- 201000002661 Spondylitis Diseases 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 206010003246 arthritis Diseases 0.000 claims description 7
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 5
- 239000011505 plaster Substances 0.000 claims description 5
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 239000002398 materia medica Substances 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000002917 arthritic effect Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000009693 chronic damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition, by the world blueness of 1.5 parts by weight red, 1 parts by weight Impatientis, the perilla leaf of 1 parts by weight, the carpet bugle of 1.5 parts by weight, the evodia rutaecarpa of 2.5 parts by weight, the achene of Siberian cocklebur of 1.5 parts by weight, the Bailey Myospalax Born of 2 parts by weight, the silky ant of 1.5 parts by weight, 1.5 parts by weight gentianae macrophyllae form.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to a kind of Chinese medicine composition, preparation and application.
Background technique
Cervical vertebra inflammation is to refer to the clinical symptoms and sign showed after cervical spine lesion.It is a kind of frequently-occurring disease, in 40-60
Year is high incidence age, and disease incidence is 100% after 70 years old.But develop now in gradually rejuvenation.The generation of cervical spondylosis with
Acute and chronic injury, occupational characteristic and the constitution of individual of cervical vertebra include that inherited trait has close relationship, furthermore personal life
Habit and eating habit have certain influence.The treatment of cervical vertebra inflammation is a comprehensive therapeutic process, and daily protection is pre-
Prevent extremely important.
Arthritis (arthritis) refers to generation in human synovial and its surrounding tissue, by inflammation, infection, degeneration, wound
Or inflammatory disease caused by other factors, tens of kinds can be divided into.The arthritic in China has 100,000,000 or more, and number is continuous
Increase.Clinical manifestation is the red, swollen, hot of joint, pain, dysfunction and joint deformity, and serious person leads to joint deformity, influences to suffer from
Person's quality of life.Half suffers from osteoarthritis, 90% women and 80% in over-65s crowd in China 50 years old or more crowd according to statistics
Male suffers from osteoarthritis.The illness rate in China is 0.34%~0.36%, and serious person's service life about shortens 10~15 years.
The protrasion of the lumbar intervertebral disci is relatively conventional one of illness, is primarily due to lumber ertebral disc each section (nucleus pulposus, fiber
Ring and cartilage plate), especially nucleus pulposus, after having different degrees of degenerative change, under the action of external force factor, the fibre of interverbebral disc
Ring breakage is tieed up, nucleus pulposus in rear or intraspinal tube, causes adjacent spinal nerve root to be pierced from rupture place prominent (or abjection)
Swash or oppress, to generate flank pain.
Ointment or plaster now on the market mainly uses activating microcirculation and removing stasis medicinal and analgesic treatment means for joint part
It is treated, but it due to being only limitted to activating microcirculation and removing stasis medicinal, therapeutic domain is smaller, chronic cervical vertebra inflammation therapeutic effect is very slow
Or it is difficult to treat, protrusion of lumber intervertebral disc is difficult to control.
Summary of the invention
It is an object of that present invention to provide Chinese medicine compositions, can control arthritis, cervical vertebra inflammation and protrusion of lumber intervertebral disc
It treats.
To achieve the goals above, the technical solution adopted by the present invention is as follows:
Chinese medicine composition, red, 1 parts by weight Impatientis, the perilla leaf of 1 parts by weight, 1.5 weight by the world blueness of 1.5 parts by weight
Part carpet bugle, the evodia rutaecarpa of 2.5 parts by weight, the achene of Siberian cocklebur of 1.5 parts by weight, the Bailey Myospalax Born of 2 parts by weight, 1.5 parts by weight it is black
Ant, 1.5 parts by weight gentianae macrophyllae composition.
Chinese materia medica preparation, the externally applied ointment being prepared by above-mentioned Chinese medicine composition.
Above-mentioned Chinese medicine composition is applied in the drug for the treatment of of arthritis.
Above-mentioned Chinese medicine composition is applied in the drug for the treatment of cervical vertebra inflammation.
Above-mentioned Chinese medicine composition is applied in the drug for the treatment of protrusion of lumber intervertebral disc.
Above-mentioned Chinese materia medica preparation the preparation method comprises the following steps: above-mentioned a variety of drugs are purified, purify the medical fluid for 98%, then
It is mixed according to said ratio.
The use process of above-mentioned Chinese materia medica preparation are as follows: after mixing the mixed liquor of above-mentioned a variety of drugs with ethyl alcohol, drip in gauze
On be applied with.In use, ethyl alcohol is added is to generate heat, urging makes the efficacy of a drug be rapidly reached affected part.
In the present invention,
It is reddish blackly red in the present invention, there is the effect of blood circulation, eliminating stasis to subdue swelling；Impatientis has the function of wind-damp dispelling, promoting blood circulation and stopping pain
Effect；Perilla leaf plays the role of anti-inflammation and sterilization；Carpet bugle refreshing and detoxicating, cool blood detumescence, being capable of anti-bacteria and anti-virus；Evodia rutaecarpa analgesic,
It is antibacterial, antiviral.
In the present invention, for it is arthritic treatment mainly utilize scattered silt stagnant gas blood, while can anti-inflammatory analgesic, to reach
To arthritic treatment is directed to well, also have on the market now certainly with for arthritic Chinese medicine ointment, but it is of the invention
Compared to ointment now on the market, curative effect is better, and faster, and preparation method of the invention can reduce the loss of drug effect, from
And make that curative effect is better faster.
It is mainly the cooperation promotion office of reddish blackly red and Impatientis, gentianae macrophyllae for curing protrusion of lumbar intervertebral disc in the present invention
The metabolism that portion's circulating function and recovery are locally obstructed, enables occupy-place tissue to absorb and drain, therefore between treatment lumbar vertebrae
Disk protrudes good effect, and perilla leaf, carpet bugle and evodia rutaecarpa are primarily to eliminate lumber ertebral disc pain, while to lumbar vertebrae
Inflammation caused by disk is prominent is treated, and carpet bugle is other than analgesic, additionally it is possible to so that Impatientis and reddish black red energy
It is enough to eliminate Nucleus pulposus phenomenon faster, so that curative effect is faster.
In the present invention, for cervical vertebra inflammation, reddish blackly red and carpet bugle can have good treatment to cervical vertebra inflammation caused by exogenous disease
Effect, reddish blackly red and Impatientis partner treatment can have good curative effect to it；And cervical vertebra inflammation main purpose caused by wound is
Blood stasis gas is removed, therefore the present invention also has a good therapeutic effect, and chronic cervical vertebra inflammation is due to being that prolonged strain causes, because
This needs above-mentioned composition to promote metabolic cycles, and tough sclerotin removes cervical vertebrae hyperosteogeny, to treat chronic cervical vertebra inflammation
And its caused pain.
Certainly, since composition of the invention can remove extravasated blood silt gas, also there is good therapeutic effect to strain.
The medication amount that the present invention uses is few, therefore low in cost, on this basis, also has very well to above-mentioned a variety of diseases
Curative effect, while it is quick.
The application method of above-mentioned traditional Chinese medicine plaster are as follows: by plaster in pain affected part, every one patch of 15h replacement.
Specific embodiment
The invention discloses Chinese medicine composition, preparation and application, those skilled in the art can use for reference present disclosure, suitably
Improve realization of process parameters.In particular, it should be pointed out that all similar substitutions and modifications are for a person skilled in the art
It will be apparent that they are considered as being included in the present invention.Method and application of the invention is carried out by preferred embodiment
Description, related personnel obviously can not depart from the content of present invention, in spirit and scope to method described herein and application into
Row change or appropriate changes and combinations, carry out implementation and application the technology of the present invention.
Embodiment
Traditional Chinese medicine plaster, by red 15 grams reddish blackly, 10 grams of Impatientis, 10 grams of perilla leaf, 15 grams of carpet bugle, 25 grams of evodia rutaecarpa,
15 grams of the achene of Siberian cocklebur, 20 grams of Bailey Myospalax Born, 15 grams of silky ant, 15 grams of gentianae macrophyllae be prepared.
Experimental example 1
By arthritis, 500 people of clinical trial number, wherein 458 people's pain completely disappear in 5 patches, remaining 42 people are in 15 patches
Pain completely disappears, this is because embodiment has good anti-inflammatory and removes the effect of silt gas, and it is mostly scorching that arthritis is prominent
Disease and intra-articular qi and blood stasis cause, and therefore, effect is ideal.
Experimental example 2
1. chronic cervical vertebra inflammation, 500 people of clinical trial number, wherein 221 people cure 20 or so, and 152 people control in 35 patch left and right
More, 127 people cure more than 45 patches.
Embodiment 3
Protrusion of lumber intervertebral disc, 500 people of clinical trial number, wherein 161 people cure in 20 patch left and right, 232 people control in 35 patch left and right
More, 107 people cure in 45 patch left and right.
Claims (5)
1. Chinese medicine composition, which is characterized in that by the world blueness of 1.5 parts by weight red, 1 parts by weight Impatientis, 1 parts by weight purple
Perilla leaf, the carpet bugle of 1.5 parts by weight, the evodia rutaecarpa of 2.5 parts by weight, the achene of Siberian cocklebur of 1.5 parts by weight, 2 parts by weight Bailey Myospalax Born,
The gentianae macrophyllae composition of the silky ant of 1.5 parts by weight, 1.5 parts by weight.
2. Chinese materia medica preparation, which is characterized in that the plaster being prepared by Chinese medicine composition described in claim 1.
3. application of the Chinese medicine composition as described in claim 1 in the drug for the treatment of of arthritis.
4. application of the Chinese medicine composition as described in claim 1 in the drug for the treatment of cervical vertebra inflammation.
5. application of the Chinese medicine composition as described in claim 1 in the drug for treating inflammation caused by protrusion of lumber intervertebral disc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811278776.4A CN109045141A (en) | 2018-10-30 | 2018-10-30 | Chinese medicine composition, preparation and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811278776.4A CN109045141A (en) | 2018-10-30 | 2018-10-30 | Chinese medicine composition, preparation and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109045141A true CN109045141A (en) | 2018-12-21 |
Family
ID=64767895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811278776.4A Pending CN109045141A (en) | 2018-10-30 | 2018-10-30 | Chinese medicine composition, preparation and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109045141A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207944A (en) * | 1998-08-31 | 1999-02-17 | 李方瑞 | Rheumatism capsule |
| CN1342462A (en) * | 2000-09-08 | 2002-04-03 | 何兴峰 | Composite medicine for treating rheumatoid arthritis |
| CN1923230A (en) * | 2005-09-02 | 2007-03-07 | 王凯 | Medicine for treating rheumatism and rheumatoid disease, and its preparation method |
| CN103316307A (en) * | 2008-04-03 | 2013-09-25 | 段云平 | Chinese herbal medicine for external use by fumigating and immersing-rheumatism and arthralgia medicine |
| CN106728347A (en) * | 2016-11-17 | 2017-05-31 | 魏聆 | A kind of FENGSHI YE and preparation method thereof |
-
2018
- 2018-10-30 CN CN201811278776.4A patent/CN109045141A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207944A (en) * | 1998-08-31 | 1999-02-17 | 李方瑞 | Rheumatism capsule |
| CN1342462A (en) * | 2000-09-08 | 2002-04-03 | 何兴峰 | Composite medicine for treating rheumatoid arthritis |
| CN1923230A (en) * | 2005-09-02 | 2007-03-07 | 王凯 | Medicine for treating rheumatism and rheumatoid disease, and its preparation method |
| CN103316307A (en) * | 2008-04-03 | 2013-09-25 | 段云平 | Chinese herbal medicine for external use by fumigating and immersing-rheumatism and arthralgia medicine |
| CN106728347A (en) * | 2016-11-17 | 2017-05-31 | 魏聆 | A kind of FENGSHI YE and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 国家药典委员会编: "《中华人民共和国药典 临床用药须知 中药成方制剂卷 2010年版》", 30 April 2011, 中国医药科技出版社 * |
| 李艳青等: "《中医学专业知识》", 31 January 2013, 世界图书出版公司北京公司 * |
| 梅全喜: "《现代中药药理与临床应用手册》", 31 October 2008, 中国中医药出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062194B (en) | Medicine for treating bone disease and fracture and the preparing method thereof | |
| CN102861312A (en) | Plaster for treating osteoarthritis and phymatosis | |
| CN103316315A (en) | Cooling paste | |
| CN109045141A (en) | Chinese medicine composition, preparation and application | |
| CN104435499A (en) | Novel red plaster rehabilitation patch and preparation method thereof | |
| CN105688040A (en) | Plaster for treating cervical spondylotic radiculopathy | |
| CN103977367A (en) | Traditional Chinese medicament for treating qi-stagnation blood-aggregation type bedsore and preparation method thereof | |
| CN103735851B (en) | A kind of Chinese medicine preparation for the treatment of fracture | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN101850011B (en) | External medicament for treating cervical spondylosis and preparation method thereof | |
| CN1267127C (en) | Osteoproliferation medicine for external application | |
| CN103948870A (en) | Traditional Chinese medicine preparation for treating nerve headache | |
| CN103751484A (en) | External medicinal liquor for treating fibromyalgia | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN102441148A (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN109010549A (en) | Synthetism expelling wind and activating blood flow pain relieving ointment and preparation method thereof | |
| CN103127274A (en) | All-season burn and scald medicine for seasons | |
| CN102885943A (en) | External Chinese medicinal liniment for treating psoriasis | |
| CN103110879B (en) | The Chinese medicine for outer use for the treatment of stiff neck | |
| CN101690750B (en) | External medicine for curing hyperosteogeny | |
| CN101810703A (en) | Chinese medicament for treating burns and scalds | |
| CN105012600A (en) | External medicine for treating hyperostosis and herniated disk | |
| CN104667201B (en) | One kind treats bronchiectasic Chinese medicine | |
| CN108619448A (en) | A kind of plaster and preparation method thereof for treating hyperostosis | |
| CN105412889A (en) | Traditional Chinese medicinal honeyed pill for treating lumbar intervertebral disc protrusion, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181221 |